Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - gemfibrozilum inn - filmuhúðuð tafla - 600 mg

Uniunea Europeană - islandeză - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitisinón - tyrosinemias - Önnur meltingarvegi og efnaskipti vörur, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Uniunea Europeană - islandeză - EMA (European Medicines Agency)

cycle pharmaceuticals (europe) ltd - nitisinón - tyrosinemias - Önnur meltingarvegi og efnaskipti vörur, - meðferð fullorðna og börn sjúklingar með staðfest greiningu arfgenga tyrosinemia tegund 1 (haÍti-1) ásamt fæðu takmörkun týrósín og fenýlalanín.

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

opella healthcare france s.a.s. - bisacodylum inn - endaþarmsstíll - 10 mg

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

opella healthcare france s.a.s. - natrii picosulfas inn - dropar til inntöku, lausn - 7,5 mg/ml

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - carbidopum inn; levodopum inn - tafla - 12,5 mg/50 mg

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - levodopum inn; carbidopum inn - tafla - 25 mg/100 mg

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - bisacodylum inn - sýruþolin tafla og endaþarmsdreifa

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - bisacodylum inn - endaþarmsdreifa - 2 mg/ml

Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - bisacodylum inn - magasýruþolin tafla - 5 mg